e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Monitoring respiratory diseases: role of comorbidities and lung involvement
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA)
L. Chishimba, W. Zhang, A. M. Andrew Mochridge, R. M. Niven, K. Al-Shar, D. Denning (Manchester, United Kingdom)
Source:
Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Session:
Monitoring respiratory diseases: role of comorbidities and lung involvement
Session type:
Thematic Poster Session
Number:
4178
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Chishimba, W. Zhang, A. M. Andrew Mochridge, R. M. Niven, K. Al-Shar, D. Denning (Manchester, United Kingdom). Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA). Eur Respir J 2013; 42: Suppl. 57, 4178
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Asthma
Year: 2013
Effect of vitamin d therapy on the pulmonary functions in pediatric asthma and allergic rhinitis
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
25(OH) vitamin D levels in pediatric asthma and allergic rhinitis
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Vitamin D level in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and aspergillus sensitization
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis
Source: Annual Congress 2013 –Asthma
Year: 2013
Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
The allergy profile and accompanying sinonasal pathologies in patients with bronchial asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013
Allergic versus non allergic asthma: What makes the difference?
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Bronchopulmonary aspergillosis
Source: Respipedia Article
Year: 2017
LATE-BREAKING ABSTRACT: IgE immunadsorption in allergic bronchopulmonary aspergillosis: A pilot study
Source: International Congress 2016 – Novel strategies on COPD and asthma management
Year: 2016
Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
Allergic rhinitis (AR), non allergic rhinitis (NAR) and doctor-diagnosed chronic lung diseases
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept